Aethlon Medical to merge with North Immunology in all-stock deal
Aethlon Medical (AEMD) shares soared 346% premarket on Thursday as it agreed on an all-stock merger with North Immunology.
The transaction, approved by both boards, is expected to close in the first quarter of 2027.
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.